Gene Therapy Cell Culture Media Market was valued at USD 142.70 million in 2018, at a CAGR of 10.9%

Gene therapy cell culture media consists of important nutrients that provide ample energy to regulate healthy cell cycle. Moreover, it contains bovine serum, animal-derived nutrients, and growth factors like EGF, FGF, IGF, and PDGF. Growing research and development activities worldwide are prime factors for the growth of the gene therapy cell culture media. Various pharmaceutical and biotechnology companies are heavily investing in research & development of gene therapy. For instance, ‘Asklepios BioPharmaceutical Inc.’ invested USD 235 million in research & development to expand its clinical trials of gene therapy in April 2019. Similarly, ‘Pfizer’ announced an investment of USD 500 million for the construction of a gene-therapy manufacturing & research facility in Sanford, North Carolina in August 2019 Pharmaceutical & biotechnology companies are capturing the largest market share, growing at a CAGR of 10.8% in the forecast period End user segment is divided into pharmaceutical & biotechnology companies, academic institutes, research laboratory and others. In the past few years, the market has witnessed an increase in the number of research & development activities in gene therapy for developing novel drugs for the treatment of cancer, cardiovascular diseases, metabolic diseases, lysosome storage diseases, and impaired metabolic pathways. In addition, more than 60% of the pipeline-based gene therapy molecules were tested for oncological treatments in 2018. In addition, in 2018, ‘Lonza Group Ltd’ launched a new manufacturing facility in the U.S. to increase its production capacity for viral gene and virally modified cell therapy products. ‘Brammer Bio’ also opened a new manufacturing facility for clinical and commercial gene therapy in Cambridge, MA, the U.S in 2017. Got questions about your regional growth of Gene Therapy Cell Culture Media Market? Just drop us a line or call on +1 646 480 7505 Asia Pacific is the fastest growing region in the forecast period Asia Pacific is the fastest growing gene therapy market across the globe. In 2011, only 13 gene therapy trials were conducted in Asia Pacific, out of which 1 was approved by China. After 2011, out of 104 trials, more than half of gene therapies were introduced to the regional market, out of which over 36% were launched during 2014–2015. Many countries in the region are investing heavily in gene therapy research activities. For instance, Singapore government is planning to invest USD 80 million in gene therapy research & development activities, clinical trials, and manufacturing. Moreover, Indonesia, Malaysia, and Thailand have also introduced regulations to attract investors for gene therapy R&D program, which, in turn, will increase the demand for gene therapy cell culture market in the region. ANNUAL PROPORTION OF GENE THERAPY TRIALS, BY CONTINENT, 1989–2015 Key Players Some of the prominent players in the market are Lonza, HiMedia, GE Healthcare, FUJIFILM Irvine Scientific, R&D Systems, Inc. (Bio-Techne), Thermo Fisher Scientific and Sartorius AG. The market consists of a number of players such as HiMedia Ltd, Thermofischer Scientific, Lonza, Sartorius AG, R&D Systems, Inc, (Bio-Techne), GE Healthcare, Fujifilm Irvine Scientific and others. As analysed, HiMedia Ltd, Thermofischer Scientific, and Sartorious AG are leading the market in terms of market penetration. The key factors attributing to this are their broad portfolio of culture media specific to gene therapy and a greater number of geographic markets served by these key manufacturers. Players such as HiMedia, also focuses on competitive pricing to further increase the market penetration. A notable strategy to enhance the product portfolio, is being undertaken by Thermo Fisher Scientific. The company has acquired BD’s advanced bioprocessing business consisting of cell culture media, feeds, and supplements. This acquisition is expected to further augment company’s position in the market. Gene Therapy Cell Culture Market Segmentation  By Type Lysogeny Broth Chemically defined media Serum free media Specialty media Stem cell media Custom media Others By End User Pharmaceutical & Biotechnology companies Academic institutions Research laboratories Others Regions Covered America North America U.S. Canada Mexico South America Europe Western Europe UK Germany France Italy Spain Rest of Europe Eastern Europe Asia-Pacific China India Japan South Korea Australia Rest of Asia-Pacific Middle East Saudi Arabia UAE Qatar Rest of The Middle East Africa South Africa Ghana Nigeria " Crucial Insights The Report Provides:" * Known and Unknown Adjacencies Influencing the Growth of Market * Explorable Revenue Sources * Customer Behaviour Analysis * Target Partners * Customized Geographical Data Based on Customers as well as Competitors * Analysis of Market Size and CAGR between the Forecast Periods